Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Yuka Ozaki

Department of Breast Oncology, Japan
Publications

Treatment of HER2-Positive Metastatic Breast Cancer with Lymphangitic Carcinomatosis Using Triple HER2-Blockade

Lymphangitic carcinomatosis (LC) represents a rare and challenging manifestation of metastatic breast cancer, often associated with poor prognosis and limited treatment options. HER2-positive breast cancer subtype accounts for a significant proportion of metastatic cases, and targeted therapies, such as trastuzumab and pertuzumab, have demonstrated... Read More»

Yuka Ozaki

: Breast Can Curr Res 2023, 8:5

10.4172/2572-4118.1000215

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Relevant Topics
Top